![Tamar Ben-Yedidia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tamar Ben-Yedidia
Directeur Technique/Scientifique/R&D chez
BIONDVAX PHARMACEUTICALS LTD
Profil
Tamar Ben-Yedidia currently works at Scinai Immunotherapeutics Ltd., as Chief Science Officer from 2004.
Dr. Ben-Yedidia also formerly worked at Biotechnology General (Israel) Ltd., as Lab Manager from 1991 to 1994.
Dr. Ben-Yedidia received her undergraduate degree from Tel-Aviv University and doctorate degree in 2000 from Weizmann Institute of Science.
Postes actifs de Tamar Ben-Yedidia
| Sociétés | Poste | Début |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Anciens postes connus de Tamar Ben-Yedidia
| Sociétés | Poste | Fin |
|---|---|---|
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01/01/1994 |
Formation de Tamar Ben-Yedidia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
Choisissez Zonebourse 
